Dr. Leen Kawas is a prominent scientist and CEO of Athira Pharma, a biotech company that treats neurodegenerative diseases. Her work on Alzheimer’s disease has been instrumental in developing novel treatments for the condition.

Dr. Kawas’s research has focused on regenerative medicine to treat Alzheimer’s. She has discovered that a protein called hepatocyte growth factor (HGF) can stimulate the growth of new neurons in the brain, potentially reversing the damage caused by Alzheimer’s.

Her research has also led to the developing of a new drug, NDX-1017, which targets HGF to treat Alzheimer’s disease. The drug has shown promising results in clinical trials, with patients experiencing significant cognitive function and memory improvements.

In addition to her work on Alzheimer’s disease, Dr. Kawas has significantly contributed to regenerative medicine. She has published numerous papers on the subject and has been recognized for her contributions with several awards and honors.

Leen Kawas is a trailblazing scientist in neurodegenerative diseases, with a particular focus on Alzheimer’s disease. Her work on developing novel treatments for Alzheimer’s has been instrumental in advancing our understanding of the condition and improving patient outcomes.

One of Dr. Kawas’s key contributions to the field has been her research on the use of regenerative medicine to treat Alzheimer’s. Her discovery of the protein HGF and its ability to stimulate the growth of new neurons in the brain has opened up new possibilities for reversing the damage caused by Alzheimer’s.

In addition to her groundbreaking research, Dr. Kawas is a highly accomplished entrepreneur. As the CEO of Athira Pharma, she has been instrumental in driving the company’s growth and success, helping to bring new treatments to market that can potentially transform the lives of patients with Alzheimer’s disease.

Dr. Kawas’s dedication to advancing the field of regenerative medicine has also earned her numerous accolades and awards. She has been recognized for her contributions to the field with honors, such as the Women Who Mean Business award from the Puget Sound Business Journal and the Entrepreneur of the Year award from Ernst & Young.

Overall, Leen Kawas’s work in Alzheimer’s disease and regenerative medicine is groundbreaking. Through her innovative research and entrepreneurial spirit, she transforms how we approach diagnosing and treating neurodegenerative diseases, offering hope and inspiration to patients and researchers alike.